• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Improvement of idiopathic membranous nephropathy diagnosis with ultrasensitive quantitative detection of anti-phospholipase A2 receptor.

作者信息

Huang Biao, Wang Liang, Cao Ya-Nan, Zhang Yi, Zhang Jue, Xiao Hualong, Zhang Qiuhua, Wang Weidong, Sun Zhuxing, Chen Yu, Hu Zhigang, Sheng Huiming

机构信息

Jiangsu Institute of Nuclear Medicine, Wuxi, China.

Department of Laboratory Medicine, Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.

出版信息

J Allergy Clin Immunol. 2017 Jun;139(6):1988-1990.e2. doi: 10.1016/j.jaci.2016.10.020. Epub 2016 Nov 19.

DOI:10.1016/j.jaci.2016.10.020
PMID:27876629
Abstract
摘要

相似文献

1
Improvement of idiopathic membranous nephropathy diagnosis with ultrasensitive quantitative detection of anti-phospholipase A2 receptor.通过抗磷脂酶A2受体的超灵敏定量检测改善特发性膜性肾病的诊断
J Allergy Clin Immunol. 2017 Jun;139(6):1988-1990.e2. doi: 10.1016/j.jaci.2016.10.020. Epub 2016 Nov 19.
2
Ultrasensitive Quantitation of Anti-Phospholipase A2 Receptor Antibody as A Diagnostic and Prognostic Indicator of Idiopathic Membranous Nephropathy.抗磷脂酶 A2 受体抗体的超敏定量作为特发性膜性肾病的诊断和预后指标。
Sci Rep. 2017 Sep 21;7(1):12049. doi: 10.1038/s41598-017-12014-1.
3
Anti-PLA2R antibody in a secondary cause of membranous nephropathy.抗磷脂酶A2受体抗体在膜性肾病的继发原因中。
Nephrology (Carlton). 2018 Jan;23(1):94-95. doi: 10.1111/nep.12997.
4
Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor.根据抗M型磷脂酶A2受体抗体的存在情况，特发性膜性肾病的临床特征、病程及预后
Nefrologia. 2015;35(5):479-86. doi: 10.1016/j.nefro.2015.05.026. Epub 2015 Jul 7.
5
[Anti-phospholipase A2 receptor (anti-PLA2R) antibodies and idiopathic membranous nephropathy: which role in diagnosis and prognosis of this disease?].[抗磷脂酶A2受体（抗PLA2R）抗体与特发性膜性肾病：在该疾病的诊断和预后中起何种作用？]
G Ital Nefrol. 2014 May-Jun;31(3).
6
Immunological remission in PLA2R-antibody-associated membranous nephropathy: cyclophosphamide versus rituximab.磷脂酶A2受体（PLA2R）抗体相关膜性肾病的免疫缓解：环磷酰胺与利妥昔单抗对比
Kidney Int. 2018 Apr;93(4):1016-1017. doi: 10.1016/j.kint.2017.12.019.
7
The accuracy of the anti-phospholipase A2 receptor antibody in the diagnosis of idiopathic membranous nephropathy: a comparison of different cutoff values as measured by the ELISA method.抗磷脂酶A2受体抗体在特发性膜性肾病诊断中的准确性：ELISA法测量不同临界值的比较
Int Urol Nephrol. 2016 Jun;48(6):845-9. doi: 10.1007/s11255-016-1263-6. Epub 2016 Mar 26.
8
Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN).抗 M 型磷脂酶 A2 受体（PLA2R）自身抗体在特发性膜性肾病（IMN）监测疾病活动中的临床意义。
Autoimmun Rev. 2016 Feb;15(2):146-54. doi: 10.1016/j.autrev.2015.10.004. Epub 2015 Oct 23.
9
Circulating anti-PLA2R autoantibodies to monitor immunological activity in membranous nephropathy.循环抗磷脂酶A2受体自身抗体用于监测膜性肾病的免疫活性。
J Am Soc Nephrol. 2011 Aug;22(8):1400-2. doi: 10.1681/ASN.2011060610. Epub 2011 Jul 22.
10
Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.特发性膜性肾病中循环抗体水平及肾沉积抗M型磷脂酶A2受体的患病率、诊断价值及临床特征
Nefrologia. 2014 May 21;34(3):353-9. doi: 10.3265/Nefrologia.pre2013.Dec.12291. Epub 2014 Feb 10.

引用本文的文献

1
Role of PLA2R domain antibodies and epitope spreading in risk stratification and prediction of proteinuria remission in primary membranous nephropathy.磷脂酶A2受体结构域抗体及表位扩展在原发性膜性肾病蛋白尿缓解的风险分层及预测中的作用
Sci Rep. 2025 Feb 26;15(1):6868. doi: 10.1038/s41598-025-91366-5.
2
Predictive value of the domain specific PLA2R antibodies for clinical remission in patients with primary membranous nephropathy: A retrospective study.原发性膜性肾病患者 PLA2R 抗体的预测价值：一项回顾性研究。
PLoS One. 2024 May 8;19(5):e0302100. doi: 10.1371/journal.pone.0302100. eCollection 2024.
3
Quantitative detection and prognostic value of antibodies against M-type phospholipase A2 receptor and its cysteine-rich ricin domain and C-type lectin domains 1 and 6-7-8 in patients with idiopathic membranous nephropathy.
特发性膜性肾病患者抗 M 型磷脂酶 A2 受体及其富含半胱氨酸的蓖麻毒素域和 C 型凝集素域 1、6-7-8 抗体的定量检测及其预后价值。
PLoS One. 2024 Feb 22;19(2):e0298269. doi: 10.1371/journal.pone.0298269. eCollection 2024.
4
PLA2R-IgG4 antibody as a predictive biomarker of treatment effectiveness and prognostic evaluation in patients with idiopathic membranous nephropathy: a retrospective study.PLA2R-IgG4 抗体作为特发性膜性肾病患者治疗效果和预后评估的预测生物标志物：一项回顾性研究。
PeerJ. 2022 Oct 10;10:e14193. doi: 10.7717/peerj.14193. eCollection 2022.
5
Clinical Evaluation of Antiphospholipase A2 Receptor IgG4 level and Its IgG4-to-IgG Ratio Based on Quantitative Immunoassays in Idiopathic Membranous Nephropathy.特发性膜性肾病基于定量免疫分析法的抗磷脂酶 A2 受体 IgG4 水平及其 IgG4/IgG 比值的临床评估。
Biomed Res Int. 2022 May 13;2022:9127520. doi: 10.1155/2022/9127520. eCollection 2022.
6
A PLA2R-IgG4 Antibody-Based Predictive Model for Assessing Risk Stratification of Idiopathic Membranous Nephropathy.基于 PLA2R-IgG4 抗体的预测模型评估特发性膜性肾病的风险分层。
J Healthc Eng. 2021 Aug 31;2021:1521013. doi: 10.1155/2021/1521013. eCollection 2021.
7
Receptor antibody time-resolved A2 phospholipase bead immunochromatography and its application in idiopathic membranous nephropathy.受体抗体时间分辨 A2 磷脂酶珠免疫层析及其在特发性膜性肾病中的应用。
J Clin Lab Anal. 2020 Dec;34(12):e23508. doi: 10.1002/jcla.23508. Epub 2020 Aug 6.
8
Serum Antibody and Glomerular Antigen of Antiphospholipase A2 Receptor in Chinese Patients with Idiopathic Membranous Nephropathy.特发性膜性肾病患者血清抗磷脂酶 A2 受体抗体与肾小球抗原。
Biomed Res Int. 2020 May 8;2020:1693710. doi: 10.1155/2020/1693710. eCollection 2020.
9
Phospholipase A2 Receptor Autoantibodies as a Novel Serological Biomarker for Autoimmune Thyroid Disease Associated Nephropathy.磷脂酶 A2 受体自身抗体作为一种新型的自身免疫性甲状腺疾病相关肾病的血清学生物标志物。
Front Immunol. 2020 Apr 30;11:837. doi: 10.3389/fimmu.2020.00837. eCollection 2020.
10
A comparison of clinical features between idiopathic membranous nephropathy patients with and without serum antibody against phospholipase A2 receptor.伴有和不伴有抗磷脂酶A2受体血清抗体的特发性膜性肾病患者临床特征的比较
Medicine (Baltimore). 2019 Nov;98(45):e17658. doi: 10.1097/MD.0000000000017658.